RBC Capital keeps a Buy rating and $82 price target on Cytokinetics (CYTK), saying the firm remains bullish on the stock following the ...

Investing.com -- Galderma Group AG has been downgraded by RBC Capital Markets to "sector perform" from "outperform," ...

RBC Capital analyst Leonid Timashev maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report) today and set a price target of ...

Royal Bank of Canada beat estimates on higher results in its capital-markets and wealth-management divisions as both units ...

RBC Capital Markets head of U.S. equity strategy research Lori Calvasina there's a rising risk of what she calls a growth scare, which would drag the S&P 500 between 14% and 20% from its peak. But she ...

Constellation Brands' (STZ) beer business likely faced several pressures in the fiscal fourth quarter, prompting the company to lower its growth outlook for the division when it reports results next ...

Three of Canada's big five lenders - Royal Bank of Canada, TD Bank and CIBC - on Thursday beat analyst expectations for ...

Frances Donald, RBC Capital Markets chief economist and Adam Phillips, EP Wealth Advisors managing director of investments, ...

RBC Capital Markets Financial Institutions Conference March 4, 2025 8:00 AM ETCompany ParticipantsDave McKay - ...

Market reactions to tariff threats from Donald Trump have been relatively muted so far, RBC Capital Markets strategists said ...

Toronto-Dominion Bank beat estimates on better-than-expected wealth-management and capital-markets results, capping off an ...

In the second quarter of last year, RBC closed its deal to takeover HSBC Bank Canada, which was Canada’s seventh-largest ...